Isolation and Characterization of Targeting-HBsAg VNAR Single Domain Antibodies from Whitespotted Bamboo Sharks (Chiloscyllium plagiosum)
Marine Drugs · 2023
DOI: 10.3390/md21040237 ↗Kurz gefasst
Fachartikel in der Zeitschrift Marine Drugs, 2023. Verfasst von Xierui Jiang und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Advanced Manufacturing, Fuzhou University, Quanzhou 362251, China. Hauptthemen laut MEDLINE: Single-Domain Antibodies, Sharks. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Outstanding Young Talent Project, the Ministry of Natural Resources of China, Scientific Research Foundation of Third Institute of Oceanography, Natural Science Foundation of Xiamen, China.
Abstract (Originalsprache)
Immunoglobulin new antigen receptor (IgNAR) is a naturally occurring antibody that consists of only two heavy chains with two independent variable domains. The variable binding domain of IgNAR, called variable new antigen receptor (VNAR), is attractive due to its solubility, thermal stability, and small size. Hepatitis B surface antigen (HBsAg) is a viral capsid protein found on the surface of the Hepatitis B virus (HBV). It appears in the blood of an individual infected with HBV and is widely used as a diagnostic marker for HBV infection. In this study, the whitespotted bamboo sharks (Chiloscyllium plagiosum) were immunized with the recombinant HBsAg protein. Peripheral blood leukocytes (PBLs) of immunized bamboo sharks were further isolated and used to construct a VNAR-targeted HBsAg phage display library. The 20 specific VNARs against HBsAg were then isolated by bio-panning and phage ELISA. The 50% of maximal effect (EC50) of three nanobodies, including HB14, HB17, and HB18, were 4.864 nM, 4.260 nM, and 8.979 nM, respectively. The Sandwich ELISA assay further showed that these three nanobodies interacted with different epitopes of HBsAg protein. When taken together, our results provide a new possibility for the application of VNAR in HBV diagnosis and also demonstrate the feasibility of using VNAR for medical testing.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Advanced Manufacturing, Fuzhou University, Quanzhou 362251, China.
- Key Laboratory of Marine Genetic Resources, State Key Laboratory Breeding Base of Marine Genetic Resources, Fujian Key Laboratory of Marine Genetic Resources, Fujian Collaborative Innovation Centre for Exploitation and…
- Key Laboratory of Ministry of Education for Conservation and Utilization of Special Biological Resources in the Western, Life Science School, Ningxia University, Yinchuan 750021, China.
- Co-Innovation Center of Jiangsu Marine Bio-Industry Technology, Jiangsu Ocean University, Lianyungang 222005, China.
ORCID-Profile: Mingliang Chen
Förderung
- Outstanding Young Talent Project, the Ministry of Natural Resources of China
- Scientific Research Foundation of Third Institute of Oceanography
- Natural Science Foundation of Xiamen, China
- Deep-Sea Habitats Discovery Project
- Xiamen Southern Oceanographic Centre Project
- Science and Technology Project of Fujian Province
Zitieren
APA
Jiang, X., Sun, S., Li, Z., & Chen, M. (2023). Isolation and Characterization of Targeting-HBsAg VNAR Single Domain Antibodies from Whitespotted Bamboo Sharks (Chiloscyllium plagiosum). Marine Drugs. https://doi.org/10.3390/md21040237
Vancouver
Jiang X, Sun S, Li Z, Chen M. Isolation and Characterization of Targeting-HBsAg VNAR Single Domain Antibodies from Whitespotted Bamboo Sharks (Chiloscyllium plagiosum). Marine Drugs. 2023. doi:10.3390/md21040237
BibTeX
@article{Jiang2023,
author = {Jiang, Xierui and Sun, Shan and Li, Zengpeng and Chen, Mingliang},
title = {Isolation and Characterization of Targeting-HBsAg VNAR Single Domain Antibodies from Whitespotted Bamboo Sharks (Chiloscyllium plagiosum)},
journal = {Marine Drugs},
year = {2023},
doi = {10.3390/md21040237}
}
EUVIMED